Literature DB >> 15540671

Attitudes of 100 patients with chronic obstructive pulmonary disease to artificial ventilation and cardiopulmonary resuscitation.

K A Gaber1, M Barnett, Y Planchant, C R McGavin.   

Abstract

UNLABELLED: One hundred clinically stable outpatients with chronic obstructive pulmonary disease were surveyed at home by respiratory nurse specialists (RNS) about their views towards cardiopulmonary resuscitation (CPR) and in hospital ventilation. Written information about COPD, CPR and ventilation was provided and consent obtained. The breathing problem-based quality-of-life questionnaire (BP-QoL) was completed. The following information was recorded: age, sex, spirometry, hospital admissions, and antidepressant and oxygen usage in the previous year. Patients were then asked to imagine a scenario in which they were admitted to hospital and their chest condition deteriorated in spite of standard treatment. 'Having reached that stage would you wish to have noninvasive ventilation (NIV), invasive ventilation (IV) or CPR?' Three months later patients were asked to complete a postal patient satisfaction questionnaire.
RESULTS: Of 100 patients 41 were male and the mean age was 74.1 years. Fifty four patients had a FEV1 <40% and 37 had a FEV1 between 40 and 59% predicted. Twenty-four patients were on long-term oxygen therapy, eight had taken antidepressants and 56 had been admitted to hospital in the previous year. Forty-eight patients wanted all additional treatments to be attempted if needed and 12 wanted none. Nineteen patients said 'no' for CPR and 10 said 'no' for CPR and IV. There was no significant statistical difference between the groups answering 'yes' or 'no'. Seventy-six per cent of patient satisfaction questionnaires were returned. All patients were satisfied with the way they had been approached and the information received, and 98% of them thought that this issue should be discussed with all patients.
CONCLUSION: Attitudes towards resuscitation can be discussed with COPD patients by RNS without causing distress. Attitudes to resuscitation could not be predicted from parameters of respiratory disease severity or age.

Entities:  

Mesh:

Year:  2004        PMID: 15540671     DOI: 10.1191/0269216304pm944oa

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  6 in total

1.  Is hospitalisation for COPD an opportunity for advance care planning? A qualitative study.

Authors:  David Seamark; Susan Blake; Clare Seamark; Michael E Hyland; Colin Greaves; Margaret Pinnuck; David Ward; Adam Hawkins; David Halpin
Journal:  Prim Care Respir J       Date:  2012-09

2.  The effect of end-of-life discussions on perceived quality of care and health status among patients with COPD.

Authors:  Janice M Leung; Edmunds M Udris; Jane Uman; David H Au
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

Review 3.  Palliative care in chronic obstructive pulmonary disease: a review for clinicians.

Authors:  David A Seamark; Clare J Seamark; David M G Halpin
Journal:  J R Soc Med       Date:  2007-05       Impact factor: 5.344

4.  Toward optimal end-of-life care for patients with advanced chronic obstructive pulmonary disease: insights from a multicentre study.

Authors:  Graeme M Rocker; Peter M Dodek; Daren K Heyland
Journal:  Can Respir J       Date:  2008 Jul-Aug       Impact factor: 2.409

5.  Decision-making conversations for life-sustaining treatment with seriously ill patients using a Danish version of the US POLST: a qualitative study of patient and physician experiences.

Authors:  Lone Doris Tuesen; Anne Sophie Ågård; Hans-Henrik Bülow; Erik K Fromme; Hanne Irene Jensen
Journal:  Scand J Prim Health Care       Date:  2022-02-11       Impact factor: 3.147

Review 6.  Patient preferences in severe COPD and asthma: a comprehensive literature review.

Authors:  Basil G Bereza; Anders Troelsgaard Nielsen; Sverrir Valgardsson; Michiel E H Hemels; Thomas R Einarson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-04-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.